BMC Cancer
(Mar 2019)
Correction to: Cryptotanshinone activates AMPK-TSC2 axis leading to inhibition of mTORC1 signaling in cancer cells
- Wenxing Chen,
- Yanhong Pan,
- Siliang Wang,
- Yuping Liu,
- Guangying Chen,
- Liang Zhou,
- Chao Zhang,
- Wenting Ni,
- Aiyun Wang,
- Yin Lu,
- Shile Huang
Affiliations
- Wenxing Chen
- School of Pharmacy, Nanjing University of Chinese Medicine
- Yanhong Pan
- School of Pharmacy, Nanjing University of Chinese Medicine
- Siliang Wang
- School of Pharmacy, Nanjing University of Chinese Medicine
- Yuping Liu
- School of Pharmacy, Nanjing University of Chinese Medicine
- Guangying Chen
- College of Chemistry and Chemical Engineering, Hainan Normal University
- Liang Zhou
- School of Pharmacy, Nanjing University of Chinese Medicine
- Chao Zhang
- Louisiana State University Health Sciences Center
- Wenting Ni
- School of Pharmacy, Nanjing University of Chinese Medicine
- Aiyun Wang
- School of Pharmacy, Nanjing University of Chinese Medicine
- Yin Lu
- School of Pharmacy, Nanjing University of Chinese Medicine
- Shile Huang
- Louisiana State University Health Sciences Center
- DOI
-
https://doi.org/10.1186/s12885-019-5458-y
- Journal volume & issue
-
Vol. 19,
no. 1
pp.
1
– 2
Abstract
Read online
Following publication of the original article [1], the author noticed the following errors in the article.
WeChat QR code
